These findings thus not only shine light on hitherto unknown functions of dysferlin in the muscle cell but could help overcome current roadblocks in the treatment of dysferlinopathies. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.